Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
This page is for educational and research purposes only
Novo's Lars Rebien hints at possible future sale of over-the-counter weight loss drugs The pharmaceutical industry, and especially the part of the industry that Novo Nordisk is in, is currently changing to become more consumer-oriented, the new chairman of the board says
VEGF-stimulating compounds can, in principle, support the vascularization of existing tumors or accelerate the growth of pre-malignant lesions
Applying on a broken barrier
Glucagon is a hormone we usually think of as doing the opposite of weight loss medications- it raises blood sugar
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy , 12 (2), 139157
US$ 21.57
US$ 20.45
US$ 21.31
US$ 29.13
US$ 28.21
US$ 23.46
